Cargando…
A sixfold rise in concurrent day and night-time heatwaves in India under 2 °C warming
Heatwaves with severe impacts have increased and projected to become more frequent under warming climate in India. Concurrent day and nighttime heatwaves can exacerbate human discomfort causing high morbidity and mortality; however, their changes in the observed and projected climate remain unrecogn...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240077/ https://www.ncbi.nlm.nih.gov/pubmed/30446705 http://dx.doi.org/10.1038/s41598-018-35348-w |
Sumario: | Heatwaves with severe impacts have increased and projected to become more frequent under warming climate in India. Concurrent day and nighttime heatwaves can exacerbate human discomfort causing high morbidity and mortality; however, their changes in the observed and projected climate remain unrecognized. Here using observations and model simulations from climate of 20(th) century plus (C20C+) detection and attribution (D&A) and coupled model intercomparison project 5 (CMIP5) projects, we show that 1 and 3-day concurrent hot day and hot night (CHDHN) events have significantly increased during the observed climate in India. Our results show that the anthropogenic emissions contribute considerably to the increase of 1 and 3-day CHDHN events in India. The frequency of 3-day CHDHN events is projected to increase 12-fold of the current level by the end of 21(st) century and 4-fold by the mid 21(st) century under the high emission pathway of RCP 8.5. The increase in 3-day CHDHN events can be limited to only 2-fold by the end of 21(st) century under low emission scenario of RCP 2.6. One and 3-day CHDHN events are projected to increase by 4, 6, and 8 folds of the current level in India under the 1.5, 2, and 3 °C warming worlds, respectively. Restricting global mean temperature below 1.5° from the pre-industrial level can substantially reduce the risk of 1 and 3-day CHDHN events and associated implications in India. |
---|